Incoming Senate Finance Committee chairman Charles Grassley (R-IA) and Senate Democratic Whip Dick Durbin (D-IL) on Friday asked the Trump administration to put in place by year’s end its proposal to require drug manufacturers disclose list prices in direct-to-consumer advertising, and they also called on HHS and CMS to adopt additional drug-price disclosure measures. Grassley announced Friday (Nov. 16) that he would take over as Finance Committee chair from pharmaceutical industry ally Sen. Orrin Hatch (R-UT). While they signaled support...